Delivery Order SPE2DB22D1202-SPE2DB25FVLR7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $35.1K to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This competitive, non-set-aside contract is structured as a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency has awarded a delivery order valued at $5,168.73 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 11, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $2,574.00 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count units). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 23, 2025, and represents a non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 units. This is a competitively awarded, non-set-aside firm fixed price delivery order valued at $4,370.26, with an ultimate completion date of August 22, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,470.05 on August 28, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement executed under the company's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,474.96. This competitively awarded, non-set-aside contract has a firm fixed price structure and an ultimate completion date of August 18, 2025. The delivery order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves...
- The Defense Logistics Agency awarded a delivery order valued at $8,677.23 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.18 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 10s. This competitively awarded, non-set-aside contract was finalized on April 22, 2025, with an ultimate completion date of April 23, 2025, and represents a firm fixed-price delivery order. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $3,766.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Clomid 50 mg tablets (30-count unit dose packaging) with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $3,224.07 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging (30-count). This non-set-aside, competitively awarded contract features firm fixed pricing and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVLR7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $3,204.07. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply delivery. This award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of delivery orders with the Defense Logistics Agency's Medical Supply Chain, supplying pharmaceutical products ranging from brand-name and generic medications to specialty therapeutics and medical devices across multiple therapeutic domains. The company's demonstrated capability to fulfill competitive federal procurement requirements and its comprehensive global pharmaceutical support vehicle enable it to serve military healthcare programs and other government healthcare systems including the Defense Health Agency and U.S. Coast Guard. This delivery order represents one of numerous pharmaceutical supply transactions executed under the company's established prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/17/25 |